Feed RARE
RA
Ultragenyx Pharmaceutical
RARE · NASDAQ
$27.65 -3.44% (-$0.98)
1M +1.81%
Market Cap $2.7B
P/E Ratio -
Div. Yield -
ROE 411.04%
Bulios Fair Price
$195.54
607.3% upside
Aktuální cena
$27.65
Podhodnoceno Férová hodnota Nadhodnoceno
Valuation
10 /100
Expensive P/S 4.05x
P/B 297.27x
P/E N/A
Growth
100 /100
Growing Rev. growth 22.81%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 83.85%
Net margin 0.00%
FCF margin 0.00%
Quality
0 /100
Poor ROIC 0.00%
ROE 0.00%
Asset turnover 0.57x
Debt
43 /100
Moderate Debt/Equity 94.24x
Current ratio 1.89x
Net debt/EBITDA -1.35x
Stability
61 /100
Moderate Beta 0.31x
Rev. volatility 5.31%
Profitable years 0
Zeptejte se StockBota na RARE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Emil D. Kakkis
Employees
1,371
Headquarters
Novato
Nadcházející události
04 SRP
Earnings
Upcoming earnings report